PFKFB3 was overexpressed in all breast cancer cell lines and in 42.9% of brain cancer cell lines (n = 7) tested, which may be attributed to the downregulation of tRiMet31 in these cell lines. This evidence concerns the gene PFKFB3 and breast carcinoma.